Webinar

LifeSci Talks COA Series | Decoding Decentralized Trials: Navigating Novel Decentralized Research Challenges and Complexity

A Conversation with Dr. Elin Haf Davies of Aparito

DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host of new challenges, including those surrounding technical interoperability, resistance to adopting new technologies, and the need for flexibility in technology uptake at research sites. With additional considerations to be made, such as ensuring regulatory compliance, and enforcing standardized metrics in assessing DCT performance, this episode provides valuable insight into the dynamic and relatively novel landscape of decentralization in clinical trials.

Craig Lipset
Craig Lipset Co-Chair, Decentralized Trial Research Alliance (DTRA)
Mark Wade
Mark Wade Global Practice Leader/COA SME, TransPerfect Life Sciences
background image
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Webinar cover image
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.